Literature DB >> 11401469

Mechanism of reaction of melatonin with human myeloperoxidase.

M Allegra1, P G Furtmüller, G Regelsberger, M L Turco-Liveri, L Tesoriere, M Perretti, M A Livrea, C Obinger.   

Abstract

Recently, it was suggested that melatonin (N-acetyl-5-methoxytryptamine) is oxidized by activated neutrophils in a reaction most probably involving myeloperoxidase (Biochem. Biophys. Res. Commun. (2000) 279, 657-662). Myeloperoxidase (MPO) is the most abundant protein of neutrophils and is involved in killing invading pathogens. To clarify if melatonin is a substrate of MPO, we investigated the oxidation of melatonin by its redox intermediates compounds I and II using transient-state spectral and kinetic measurements at 25 degrees C. Spectral and kinetic analysis revealed that both compound I and compound II oxidize melatonin via one-electron processes. The second-order rate constant measured for compound I reduction at pH 7 and pH 5 are (6.1 +/- 0.2) x 10(6) M(-1) s(-1) and (1.0 +/- 0.08) x 10(7) M(-1) s(-1), respectively. The rates for the one-electron reduction of compound II back to the ferric enzyme are (9.6 +/- 0.3) x 10(2) M(-1) s(-1) (pH 7) and (2.2 +/- 0.1) x 10(3) M(-1) s(-1) (pH 5). Thus, melatonin is a much better electron donor for compound I than for compound II. Steady-state experiments showed that the rate of oxidation of melatonin is dependent on the H(2)O(2) concentration, is not affected by superoxide dismutase, and is quickly terminated by sodium cyanide. Melatonin can markedly inhibit the chlorinating activity of MPO at both pH 7 and pH 5. The implication of these findings in the activated neutrophil is discussed. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11401469     DOI: 10.1006/bbrc.2001.4582

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  Measurement of melatonin and its metabolites: importance for the evaluation of their biological roles.

Authors:  Glaucia R Martinez; Eduardo A Almeida; Clécio F Klitzke; Janice Onuki; Fernanda M Prado; Marisa H G Medeiros; Paolo Di Mascio
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

2.  Urate as a physiological substrate for myeloperoxidase: implications for hyperuricemia and inflammation.

Authors:  Flavia C Meotti; Guy N L Jameson; Rufus Turner; D Tim Harwood; Samantha Stockwell; Martin D Rees; Shane R Thomas; Anthony J Kettle
Journal:  J Biol Chem       Date:  2011-01-25       Impact factor: 5.157

3.  Molecular evidence that melatonin is enzymatically oxidized in a different manner than tryptophan: investigations with both indoleamine 2,3-dioxygenase and myeloperoxidase.

Authors:  Gilles Ferry; Caroline Ubeaud; Pierre-Hervé Lambert; Sophie Bertin; Francis Cogé; Pascale Chomarat; Philippe Delagrange; Bernard Serkiz; Jean-Paul Bouchet; Roger J W Truscott; Jean A Boutin
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

4.  K⁺-Cl⁻ cotransport mediates the bactericidal activity of neutrophils by regulating NADPH oxidase activation.

Authors:  Yuan-Ting Sun; Chi-Chang Shieh; Eric Delpire; Meng-Ru Shen
Journal:  J Physiol       Date:  2012-04-23       Impact factor: 5.182

Review 5.  Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence.

Authors:  Mahshid Yeganeh Salehpour; Adriano Mollica; Saeideh Momtaz; Nima Sanadgol; Mohammad Hosein Farzaei
Journal:  Clin Drug Investig       Date:  2019-07       Impact factor: 2.859

6.  Analysis of the mechanism by which melatonin inhibits human eosinophil peroxidase.

Authors:  T Lu; S Galijasevic; I Abdulhamid; H M Abu-Soud
Journal:  Br J Pharmacol       Date:  2008-06-02       Impact factor: 8.739

7.  A model of the oscillatory metabolism of activated neutrophils.

Authors:  Lars F Olsen; Ursula Kummer; Andrei L Kindzelskii; Howard R Petty
Journal:  Biophys J       Date:  2003-01       Impact factor: 4.033

8.  A novel paramagnetic substrate for detecting myeloperoxidase activity in vivo.

Authors:  Mohammed S Shazeeb; Yang Xie; Suresh Gupta; Alexei A Bogdanov
Journal:  Mol Imaging       Date:  2012 Sep-Oct       Impact factor: 4.488

9.  Triazolopyrimidines identified as reversible myeloperoxidase inhibitors.

Authors:  Franck Duclos; Lynn M Abell; David G Harden; Kristen Pike; Kimberly Nowak; Gregory A Locke; Gerald J Duke; Xiaoqin Liu; Gayani Fernando; Scott A Shaw; Benjamin P Vokits; Nicholas R Wurtz; Andrew Viet; Meriah N Valente; Sylwia Stachura; Paul Sleph; Javed A Khan; Ji Gao; Ashok R Dongre; Lei Zhao; Ruth R Wexler; David A Gordon; Ellen K Kick
Journal:  Medchemcomm       Date:  2017-10-26       Impact factor: 3.597

10.  Melatonin prevents myeloperoxidase heme destruction and the generation of free iron mediated by self-generated hypochlorous acid.

Authors:  Faten Shaeib; Sana N Khan; Iyad Ali; Tohid Najafi; Dhiman Maitra; Ibrahim Abdulhamid; Ghassan M Saed; Subramaniam Pennathur; Husam M Abu-Soud
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.